Clinical Trials in the Middle East: A Region Worth Watching Closely
Dear Clients,
As clinical research capabilities continue to develop across parts of the Middle East, life sciences companies may want to take a closer look at the region’s evolving role in global trial strategy.
Our latest client update highlights some of the trends, differences between key jurisdictions, and practical considerations for companies exploring opportunities in the region.
As always, the team at Agmon with Tulchinsky remains at your disposal.
More Relevant Media
20.05.2026
Cell Therapy in Non Muscle Invasive Bladder Cancer: A Development Life Sciences Companies Should Watch
Client updates
12.03.2026
AI in Drug Development, Biologics, and Medical Devices: Recent Signals from the FDA and EMA
Client updates
08.02.2026
AI in Clinical Trials, Moving from Pilot to Scale and the Trust Gap That Still Holds It Back
Client updates
20.01.2026
Reported Patient Death in an Innovative CRISPR Trial – Client Update – January 2026
Client updates